access to medicines
Poor-quality, or “substandard”, medicines threaten patients and public health in developing countries.
Vaccines have contributed to some of the greatest public health successes of the past century, averting 2.5 million child deaths every year and millions more bouts of illness and dis
Access to medicines poses a critical challenge in developing countries: prices are high, and new or adapted medicines and vaccines to address diseases of the developing world are lacking.
The realization of the right to health for millions of people in poor countries depends upon a massive increase in health services to achieve universal and equitable access.